Envista Holdings (NVST) Total Current Liabilities (2018 - 2026)
Envista Holdings' (NVST) quarterly Total Current Liabilities came in at $786.6 million in Q2 2026, down 9.93% year-on-year from $873.3 million in Q2 2025, and down 7.74% quarter-over-quarter from $852.6 million in Q4 2025.
Envista Holdings (NVST) Total Current Liabilities (2018 - 2026) Analysis & Trends
Envista Holdings' Total Current Liabilities history runs 9 years deep, the most recent figure standing at $786.6 million for Q2 2026.
- On a quarterly basis, Total Current Liabilities fell 9.93% year-over-year to $786.6 million in Q2 2026; TTM through Apr 2026 was $786.6 million, a 9.93% decrease from a year earlier, with the FY2025 full-year figure at $852.6 million, down 2.97% from the prior year.
- Total Current Liabilities declined to $786.6 million in Q2 2026 per NVST's latest filing, from $852.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.3 billion in Q3 2022 and bottomed at $746.8 million in Q3 2023.
- The 5-year median for Total Current Liabilities is $865.5 million (2024), against an average of $959.4 million.
- Across the five-year window, Total Current Liabilities sank 40.65% in 2023 and gained 15.89% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $1.2 billion in 2022, then sank by 36.86% to $780.8 million in 2023, then rose by 12.54% to $878.7 million in 2024, then retreated by 2.97% to $852.6 million in 2025, then declined by 7.74% to $786.6 million in 2026.
- Per Business Quant, the three latest NVST Total Current Liabilities figures stand at $786.6 million (Q2 2026), $852.6 million (Q4 2025), and $821.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn | 786.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 786.60 Mn |
| Dec 31, 2025 | 852.60 Mn |
| Sep 26, 2025 | 821.70 Mn |
| Jun 27, 2025 | 793.90 Mn |
| Mar 28, 2025 | 873.30 Mn |
| Dec 31, 2024 | 878.70 Mn |
| Sep 27, 2024 | 865.50 Mn |
| Jun 28, 2024 | 821.40 Mn |
| Mar 29, 2024 | 781.30 Mn |
| Dec 31, 2023 | 780.80 Mn |
| Sep 29, 2023 | 746.80 Mn |
| Jun 30, 2023 | 1.15 Bn |
| Mar 31, 2023 | 1.15 Bn |
| Dec 31, 2022 | 1.24 Bn |
| Sep 30, 2022 | 1.26 Bn |
| Jul 1, 2022 | 1.26 Bn |
| Apr 1, 2022 | 1.26 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Oct 1, 2021 | 1.27 Bn |
| Jul 2, 2021 | 1.16 Bn |